The association between circulating endostatin and a disturbed circadian blood pressure pattern in patients with type 2 diabetes

Blood Pressure
Jonas WuopioJohan Ärnlöv

Abstract

Endostatin, cleaved from collagen XVIII in the extracellular matrix, is a promising circulating biomarker for cardiovascular damage. It possesses anti-angiogenic and anti-fibrotic functions and has even been suggested to be involved in blood pressure regulation. Less is known if endostatin levels relate to circadian blood pressure patterns. In the present paper we studied the association between circulating levels of endostatin and nocturnal dipping in blood pressure. We used the CARDIPP-study, a cohort of middle aged, type 2 diabetics (n = 593, 32% women), with data on both 24-hour and office blood pressure, serum-endostatin, cardiovascular risk factors, and incident major cardiovascular events. Nocturnal dipping was defined as a >10% difference between day- and night-time blood pressures. Two-hundred four participants (34%) were classified as non-dippers. The mean endostatin levels were significantly higher in non-dippers compared to dippers (mean ± standard deviation: 62.6 ± 1.8 µg/l vs. 58.7 ± 1.6 µg/l, respectively, p = .007). Higher serum levels of endostatin were associated with a diminished decline in nocturnal blood pressure adjusted for age, sex, HbA1c, mean systolic day blood pressure, hypertension treatment, glomeru...Continue Reading

References

Jun 1, 1979·Journal of Mental Deficiency Research·B W Richards, F Enver
Aug 13, 1988·Lancet·E O'BrienK O'Malley
Oct 6, 1999·Current Opinion in Cell Biology·C Streuli
Mar 16, 2000·The EMBO Journal·U FelborW Mothes
Jan 10, 2002·European Journal of Human Genetics : EJHG·T S ZorickM R Passos-Bueno
Dec 17, 2004·Pharmacological Reviews·Ann HoebenErnst A De Bruijn
Jun 9, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Amir AbdollahiPeter E Huber
Dec 27, 2005·Experimental Cell Research·Judah Folkman
Apr 1, 2006·Circulation Research·D WenzelB K Fleischmann
Apr 25, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·E M DahlénC J Ostgren
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Oct 2, 2009·The Journal of Craniofacial Surgery·Sandra Ryeom, Judah Folkman
Mar 5, 2010·Current Diabetes Reviews·Cesare CuspidiCarla Sala
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sarah B SunshineMaria Rupnick
Dec 19, 2012·Frontiers in Genetics·Bernard J van VarikLeon J Schurgers
Sep 14, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Johan ÄrnlövLars Lind
Jan 7, 2014·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Yukie Yamaguchi, Carol A Feghali-Bostwick
Jan 8, 2014·Cardiovascular Diabetology·Michael SponderJeanette Strametz-Juranek
Nov 18, 2014·American Journal of Nephrology·Toralph RugeJohan Ärnlöv
Apr 18, 2015·Journal of Hypertension·Mohd S DramanEoin O'Brien
Oct 27, 2016·Heart, Lung & Circulation·Benjamin B AlbertWayne S Cutfield
Sep 6, 2017·Journal of the Neurological Sciences·Georgios TsivgoulisEfstathios Manios
Oct 5, 2017·Biomarkers in Medicine·Toralph RugeJohan Ärnlöv

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.